JunD/AP-1 Antagonizes the Induction of DAPK1 To Promote the Survival of v-Src-Transformed Cells

Bart M Maślikowski1, Lizhen Wang1, Ying Wu1

  • 1Department of Biology, McMaster University, Hamilton, Ontario, Canada.

Journal of Virology
|November 1, 2016
PubMed

Insights

JunD, a component of AP-1, promotes survival in v-Src-transformed cells by antagonizing death-associated protein kinase 1 (DAPK1). Loss of JunD activates a cell death program involving DAPK1, highlighting v-Src

Area of Science:

  • Cellular transformation
  • Oncogenesis
  • Gene regulation

Background:

  • AP-1 activity increases during cell transformation by tyrosine kinases.
  • JunD, a component of AP-1, enhances cell survival in v-Src-transformed cells.
  • v-Src oncoprotein alters gene expression, influencing transformed cell properties.

Purpose of the Study:

  • Investigate the role of AP-1 in v-Src-mediated transformation.
  • Characterize transcriptomes of v-Src-transformed cells with impaired AP-1/JunD.
  • Elucidate the mechanism of JunD-mediated cell survival.

Main Methods:

  • Gene profiling of v-Src-transformed chicken embryo fibroblasts (CEFs).
  • Utilized c-Jun dominant-negative mutant (TAM67) and JunD short hairpin RNA (shRNA).
  • Chromatin immunoprecipitation (ChIP) assays to assess protein-DNA interactions.

Main Results:

  • A cluster of 18 probe sets upregulated upon AP-1/JunD impairment in v-Src-transformed CEFs.
  • Identified death-associated protein kinase 1 (DAPK1) as a key mediator of apoptosis.
  • JunD antagonizes DAPK1 expression, promoting survival; inhibition of DAPK1 abrogates v-Src-induced cell death.

Conclusions:

  • JunD promotes cell survival in v-Src-transformed cells by indirectly inhibiting DAPK1.
  • Loss of JunD activates a cell death program dependent on DAPK1.
  • v-Src employs multiple mechanisms to antagonize DAPK1's tumor suppressor function.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K